Am. J. Respir. Crit. Care Med., Vol 154, No. 4, Oct 1996, 1055-1060.
Systemic oxidative stress in asthma, COPD, and smokers
I Rahman, D Morrison, K Donaldson and W MacNee
Department of Medicine, University of Edinburgh, Royal Infirmary, Scotland, United Kingdom.
An imbalance between oxidants and antioxidants is proposed in smokers and
in patients with airways diseases. We tested this hypothesis by measuring
the Trolox equivalent antioxidant capacity (TEAC) of plasma and the levels
of products of lipid peroxidation as indices of overall oxidative stress.
The plasma TEAC was markedly reduced (0.66 +/- 0.07 mmol/L; mean +/- SEM; n
= 11), with increased levels of lipid peroxidation products, in healthy
chronic smokers as compared with healthy nonsmokers (1.31 +/- 0.10 mmol/L,
n = 14, p < 0.001), an effect that was exaggerated in those who had
smoked 1 h before the study. Plasma TEAC was also low in patients
presenting with acute exacerbations of chronic obstructive pulmonary
disease (COPD) (0.46 +/- 0.10 mmol/L, n = 20, p < 0.001) or asthma (0.61
+/- 0.05 mmol/L, n = 9, p < 0.01) with increases in plasma lipid
peroxidation products. There was a negative correlation between superoxide
anion release by stimulated neutrophils and plasma antioxidant capacity (r
= -0.73, p < 0.001) in patients with acute exacerbations of COPD. The
profound decrease in TEAC was associated with a decreased plasma protein
sulfhydryl concentrations in acute exacerbations of COPD but not in smokers
or in asthmatic subjects. Therefore smoking, acute exacerbations of COPD,
and asthma are associated with a marked oxidant/antioxidant imbalance in
the blood, associated with evidence of increased oxidative stress. The
decreased antioxidant capacity in plasma may result from different
mechanisms in these conditions.
This article has been cited by other articles:

|
 |

|
 |
 
Y. M. Hosakote, T. Liu, S. M. Castro, R. P. Garofalo, and A. Casola
Respiratory Syncytial Virus Induces Oxidative Stress by Modulating Antioxidant Enzymes
Am. J. Respir. Cell Mol. Biol.,
September 1, 2009;
41(3):
348 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. G. Tzortzaki and N. M. Siafakas
A hypothesis for the initiation of COPD
Eur. Respir. J.,
August 1, 2009;
34(2):
310 - 315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B G Cosio, A Iglesias, A Rios, A Noguera, E Sala, K Ito, P J Barnes, and A Agusti
Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD
Thorax,
May 1, 2009;
64(5):
424 - 429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Sussan, T. Rangasamy, D. J. Blake, D. Malhotra, H. El-Haddad, D. Bedja, M. S. Yates, P. Kombairaju, M. Yamamoto, K. T. Liby, et al.
From the Cover: Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice
PNAS,
January 6, 2009;
106(1):
250 - 255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Rahman
Review: Antioxidant therapeutic advances in COPD
Therapeutic Advances in Respiratory Disease,
December 1, 2008;
2(6):
351 - 374.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. MacNee, J. Maclay, and D. McAllister
Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
December 1, 2008;
5(8):
824 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Future Treatments for Chronic Obstructive Pulmonary Disease and Its Comorbidities
Proceedings of the ATS,
December 1, 2008;
5(8):
857 - 864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. S. Cho, S. Y. Oh, and Z. Zhu
Tyrosine Phosphatase SHP-1 in Oxidative Stress and Development of Allergic Airway Inflammation
Am. J. Respir. Cell Mol. Biol.,
October 1, 2008;
39(4):
412 - 419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yao, S.-R. Yang, I. Edirisinghe, S. Rajendrasozhan, S. Caito, D. Adenuga, M. A. O'Reilly, and I. Rahman
Disruption of p21 Attenuates Lung Inflammation Induced by Cigarette Smoke, LPS, and fMLP in Mice
Am. J. Respir. Cell Mol. Biol.,
July 1, 2008;
39(1):
7 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Petrache, T. R. Medler, A. T. Richter, K. Kamocki, U. Chukwueke, L. Zhen, Y. Gu, J. Adamowicz, K. S. Schweitzer, W. C. Hubbard, et al.
Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide
Am J Physiol Lung Cell Mol Physiol,
July 1, 2008;
295(1):
L44 - L53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yao, I. Edirisinghe, S. Rajendrasozhan, S.-R. Yang, S. Caito, D. Adenuga, and I. Rahman
Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice
Am J Physiol Lung Cell Mol Physiol,
June 1, 2008;
294(6):
L1174 - L1186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yao, I. Edirisinghe, S.-R. Yang, S. Rajendrasozhan, A. Kode, S. Caito, D. Adenuga, and I. Rahman
Genetic Ablation of NADPH Oxidase Enhances Susceptibility to Cigarette Smoke-Induced Lung Inflammation and Emphysema in Mice
Am. J. Pathol.,
May 1, 2008;
172(5):
1222 - 1237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fuschillo, A. De Felice, and G. Balzano
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms
Eur. Respir. J.,
February 1, 2008;
31(2):
396 - 406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Complex chronic comorbidities of COPD
Eur. Respir. J.,
January 1, 2008;
31(1):
204 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Montes de Oca, E. Loeb, S. H. Torres, J. De Sanctis, N. Hernandez, and C. Talamo
Peripheral Muscle Alterations in Non-COPD Smokers
Chest,
January 1, 2008;
133(1):
13 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Abusriwil and R. A. Stockley
The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage
Proceedings of the ATS,
December 1, 2007;
4(8):
611 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tkac, S. F. P. Man, and D. D. Sin
Review: Systemic consequences of COPD
Therapeutic Advances in Respiratory Disease,
October 1, 2007;
1(1):
47 - 59.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Agusti
Systemic Effects of Chronic Obstructive Pulmonary Disease: What We Know and What We Don't Know (but Should)
Proceedings of the ATS,
October 1, 2007;
4(7):
522 - 525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hoshino, T. Nakamura, A. Sato, M. Mishima, J. Yodoi, and H. Nakamura
Neurotropin Demonstrates Cytoprotective Effects in Lung Cells through the Induction of Thioredoxin-1
Am. J. Respir. Cell Mol. Biol.,
October 1, 2007;
37(4):
438 - 446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Pinto-Plata, J. Toso, K. Lee, D. Park, J. Bilello, H. Mullerova, M. M De Souza, R. Vessey, and B. Celli
Profiling serum biomarkers in patients with COPD: associations with clinical parameters
Thorax,
July 1, 2007;
62(7):
595 - 601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Paredi, S. Ward, D. Cramer, P. J. Barnes, and S. A. Kharitonov
Normal Bronchial Blood Flow in COPD Is Unaffected by Inhaled Corticosteroids and Correlates With Exhaled Nitric Oxide
Chest,
April 1, 2007;
131(4):
1075 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Stolz, M. Christ-Crain, R. Bingisser, J. Leuppi, D. Miedinger, C. Muller, P. Huber, B. Muller, and M. Tamm
Antibiotic Treatment of Exacerbations of COPD: A Randomized, Controlled Trial Comparing Procalcitonin-Guidance With Standard Therapy
Chest,
January 1, 2007;
131(1):
9 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Castro, A. Guerrero-Plata, G. Suarez-Real, P. A. Adegboyega, G. N. Colasurdo, A. M. Khan, R. P. Garofalo, and A. Casola
Antioxidant Treatment Ameliorates Respiratory Syncytial Virus-induced Disease and Lung Inflammation
Am. J. Respir. Crit. Care Med.,
December 15, 2006;
174(12):
1361 - 1369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Singh, T. Rangasamy, R. K. Thimmulappa, H. Lee, W. O. Osburn, R. Brigelius-Flohe, T. W. Kensler, M. Yamamoto, and S. Biswal
Glutathione Peroxidase 2, the Major Cigarette Smoke-Inducible Isoform of GPX in Lungs, Is Regulated by Nrf2
Am. J. Respir. Cell Mol. Biol.,
December 1, 2006;
35(6):
639 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Lee, S. R. Kim, S. J. Park, K. H. Min, K. Y. Lee, S. M. Jin, W. H. Yoo, and Y. C. Lee
Antioxidant Down-Regulates Interleukin-18 Expression in Asthma
Mol. Pharmacol.,
October 1, 2006;
70(4):
1184 - 1193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-C. L. Machado, J. A. Krishnan, S. A. Buist, A. L. Bilderback, G. P. Fazolo, M. G. Santarosa, F. Queiroga Jr., and W. M. Vollmer
Sex Differences in Survival of Oxygen-dependent Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
September 1, 2006;
174(5):
524 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Hirano, T Yamagata, M Gohda, Y Yamagata, T Ichikawa, S Yanagisawa, K Ueshima, K Akamatsu, M Nakanishi, K Matsunaga, et al.
Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline
Thorax,
September 1, 2006;
61(9):
761 - 766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Celli
Roger S. Mitchell Lecture. Chronic Obstructive Pulmonary Disease Phenotypes and Their Clinical Relevance
Proceedings of the ATS,
August 1, 2006;
3(6):
461 - 465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Agusti
Thomas A. Neff Lecture. Chronic Obstructive Pulmonary Disease: A Systemic Disease
Proceedings of the ATS,
August 1, 2006;
3(6):
478 - 481.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Tuder, T. Yoshida, W. Arap, R. Pasqualini, and I. Petrache
State of the Art. Cellular and Molecular Mechanisms of Alveolar Destruction in Emphysema: An Evolutionary Perspective
Proceedings of the ATS,
August 1, 2006;
3(6):
503 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Baginski, K. Dabbagh, C. Satjawatcharaphong, and D. C. Swinney
Cigarette Smoke Synergistically Enhances Respiratory Mucin Induction by Proinflammatory Stimuli
Am. J. Respir. Cell Mol. Biol.,
August 1, 2006;
35(2):
165 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Matsui, T. Shimosawa, Y. Uetake, H. Wang, S. Ogura, T. Kaneko, J. Liu, K. Ando, and T. Fujita
Protective Effect of Potassium Against the Hypertensive Cardiac Dysfunction: Association With Reactive Oxygen Species Reduction
Hypertension,
August 1, 2006;
48(2):
225 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Rahman and I. M. Adcock
Oxidative stress and redox regulation of lung inflammation in COPD.
Eur. Respir. J.,
July 1, 2006;
28(1):
219 - 242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Ochs-Balcom, B. J. B. Grant, P. Muti, C. T. Sempos, J. L. Freudenheim, R. W. Browne, M. Trevisan, L. Iacoviello, P. A. Cassano, and H. J. Schunemann
Oxidative Stress and Pulmonary Function in the General Population
Am. J. Epidemiol.,
December 15, 2005;
162(12):
1137 - 1145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. MacNee
Pathogenesis of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
November 1, 2005;
2(4):
258 - 266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mallia and S. L. Johnston
Mechanisms and Experimental Models of Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS,
November 1, 2005;
2(4):
361 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. N. Agusti
Systemic Effects of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
November 1, 2005;
2(4):
367 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Owen
Proteinases and Oxidants as Targets in the Treatment of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
November 1, 2005;
2(4):
373 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Papageorgiou, K. Kostikas, T. Kiropoulos, E. Karetsi, G. Mpatavanis, and K. I. Gourgoulianis
Increased Oxidative Stress in Exudative Pleural Effusions: A New Marker for the Differentiation Between Exudates and Transudates?
Chest,
November 1, 2005;
128(5):
3291 - 3297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Lee, H. S. Park, S. J. Park, S. R. Kim, K. H. Min, S. M. Jin, K.-H. Park, U.-H. Kim, C. Y. Kim, and Y. C. Lee
A Prodrug of Cysteine, L-2-Oxothiazolidine-4-carboxylic Acid, Regulates Vascular Permeability by Reducing Vascular Endothelial Growth Factor Expression in Asthma
Mol. Pharmacol.,
November 1, 2005;
68(5):
1281 - 1290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Couillard and C. Prefaut
From muscle disuse to myopathy in COPD: potential contribution of oxidative stress
Eur. Respir. J.,
October 1, 2005;
26(4):
703 - 719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. MacNee
Treatment of stable COPD: antioxidants
Eur. Respir. Rev.,
September 1, 2005;
14(94):
12 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. A. Misso, J. Brooks-Wildhaber, S. Ray, H. Vally, and P. J. Thompson
Plasma concentrations of dietary and nondietary antioxidants are low in severe asthma
Eur. Respir. J.,
August 1, 2005;
26(2):
257 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tsoumakidou, N. Tzanakis, G. Chrysofakis, and N. M. Siafakas
Nitrosative Stress, Heme Oxygenase-1 Expression and Airway Inflammation During Severe Exacerbations of COPD
Chest,
June 1, 2005;
127(6):
1911 - 1918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. M. Wouters
Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
April 1, 2005;
2(1):
26 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. MacNee
Pulmonary and Systemic Oxidant/Antioxidant Imbalance in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
April 1, 2005;
2(1):
50 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E M Drost, K M Skwarski, J Sauleda, N Soler, J Roca, A Agusti, and W MacNee
Oxidative stress and airway inflammation in severe exacerbations of COPD
Thorax,
April 1, 2005;
60(4):
293 - 300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hodge, G. Hodge, M. Holmes, and P. N. Reynolds
Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation
Eur. Respir. J.,
March 1, 2005;
25(3):
447 - 454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Wood, M. L. Garg, J. L. Simpson, T. A. Mori, K. D. Croft, P. A. B. Wark, and P. G. Gibson
Induced Sputum 8-Isoprostane Concentrations in Inflammatory Airway Diseases
Am. J. Respir. Crit. Care Med.,
March 1, 2005;
171(5):
426 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Corradi, P. Pignatti, P. Manini, R. Andreoli, M. Goldoni, M. Poppa, G. Moscato, B. Balbi, and A. Mutti
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation
Eur. Respir. J.,
December 1, 2004;
24(6):
1011 - 1017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev.,
December 1, 2004;
56(4):
515 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P J K Pearson, S A Lewis, J Britton, and A Fogarty
Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial
Thorax,
August 1, 2004;
59(8):
652 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H van der Vaart, D S Postma, W Timens, and N H T Ten Hacken
Acute effects of cigarette smoke on inflammation and oxidative stress: a review
Thorax,
August 1, 2004;
59(8):
713 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Carter, C. Garat, and M. Imamura
Continual emerging roles of HO-1: protection against airway inflammation
Am J Physiol Lung Cell Mol Physiol,
July 1, 2004;
287(1):
L24 - L25.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Koechlin, A. Couillard, J.P. Cristol, P. Chanez, M. Hayot, D. Le Gallais, and C. Prefaut
Does systemic inflammation trigger local exercise-induced oxidative stress in COPD?
Eur. Respir. J.,
April 1, 2004;
23(4):
538 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.N.R. Dekhuijzen
Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease
Eur. Respir. J.,
April 1, 2004;
23(4):
629 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.W. Boots, G.R.M.M. Haenen, and A. Bast
Oxidant metabolism in chronic obstructive pulmonary disease
Eur. Respir. J.,
November 2, 2003;
22(46_suppl):
14s - 27s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Orozco-Levi
Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation?
Eur. Respir. J.,
November 2, 2003;
22(46_suppl):
41s - 51s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sato, K. Nishimura, H. Koyama, M. Tsukino, T. Oga, T. Hajiro, and M. Mishima
Optimal Cutoff Level of Breath Carbon Monoxide for Assessing Smoking Status in Patients With Asthma and COPD
Chest,
November 1, 2003;
124(5):
1749 - 1754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Wickenden, M. C. H. Clarke, A. G. Rossi, I. Rahman, S. P. Faux, K. Donaldson, and W. MacNee
Cigarette Smoke Prevents Apoptosis through Inhibition of Caspase Activation and Induces Necrosis
Am. J. Respir. Cell Mol. Biol.,
November 1, 2003;
29(5):
562 - 570.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P.J. Barnes, S.D. Shapiro, and R.A. Pauwels
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Eur. Respir. J.,
October 1, 2003;
22(4):
672 - 688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ichinose, H. Sugiura, S. Yamagata, A. Koarai, M. Tomaki, H. Ogawa, Y. Komaki, P.J. Barnes, K. Shirato, and T. Hattori
Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways
Eur. Respir. J.,
September 1, 2003;
22(3):
457 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Hackett, A. Heguy, B.-G. Harvey, T. P. O'Connor, K. Luettich, D. B. Flieder, R. Kaplan, and R. G. Crystal
Variability of Antioxidant-Related Gene Expression in the Airway Epithelium of Cigarette Smokers
Am. J. Respir. Cell Mol. Biol.,
September 1, 2003;
29(3):
331 - 343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.R. Gosker, P. Schrauwen, M.K.C. Hesselink, G. Schaart, G.J. van der Vusse, E.F.M. Wouters, and A.M.W.J. Schols
Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD
Eur. Respir. J.,
July 1, 2003;
22(1):
88 - 93.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Corradi, I. Rubinstein, R. Andreoli, P. Manini, A. Caglieri, D. Poli, R. Alinovi, and A. Mutti
Aldehydes in Exhaled Breath Condensate of Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
May 15, 2003;
167(10):
1380 - 1386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W A Biernacki, S A Kharitonov, and P J Barnes
Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD
Thorax,
April 1, 2003;
58(4):
294 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Paredi, G. Caramori, D. Cramer, S. Ward, A. Ciaccia, A. Papi, S.A. Kharitonov, and P.J. Barnes
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease
Eur. Respir. J.,
March 1, 2003;
21(3):
439 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.G.N. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets
Systemic effects of chronic obstructive pulmonary disease
Eur. Respir. J.,
February 1, 2003;
21(2):
347 - 360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kantengwa, L. Jornot, C. Devenoges, and L. P. Nicod
Superoxide Anions Induce the Maturation of Human Dendritic Cells
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
431 - 437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.G. Wood, P.G. Gibson, and M.L. Garg
Biomarkers of lipid peroxidation, airway inflammation and asthma
Eur. Respir. J.,
January 1, 2003;
21(1):
177 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E F M Wouters
Chronic obstructive pulmonary disease * 5: Systemic effects of COPD
Thorax,
December 1, 2002;
57(12):
1067 - 1070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Couillard, C. Koechlin, J.P. Cristol, A. Varray, and C. Prefaut
Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients
Eur. Respir. J.,
November 1, 2002;
20(5):
1123 - 1129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. K. Russell, A. Thorley, S. V. Culpitt, S. Dodd, L. E. Donnelly, C. Demattos, M. Fitzgerald, and P. J. Barnes
Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases
Am J Physiol Lung Cell Mol Physiol,
October 1, 2002;
283(4):
L867 - L873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Harju, R. Kaarteenaho-Wiik, Y. Soini, R. Sormunen, and V. L. Kinnula
Diminished Immunoreactivity of {gamma}-Glutamylcysteine Synthetase in the Airways of Smokers' Lung
Am. J. Respir. Crit. Care Med.,
September 1, 2002;
166(5):
754 - 759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Rahman, A. A. M. van Schadewijk, A. J. L. Crowther, P. S. Hiemstra, J. Stolk, W. MacNee, and W. I. De Boer
4-Hydroxy-2-Nonenal, a Specific Lipid Peroxidation Product, Is Elevated in Lungs of Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
August 15, 2002;
166(4):
490 - 495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Kim, X. Liu, H. Wang, T. Kohyama, T. Kobayashi, F.-Q. Wen, D. J. Romberger, S. Abe, W. MacNee, I. Rahman, et al.
Glutathione prevents inhibition of fibroblast-mediated collagen gel contraction by cigarette smoke
Am J Physiol Lung Cell Mol Physiol,
August 1, 2002;
283(2):
L409 - L417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sohy, C. Pilette, M.S. Niederman, and Y. Sibille
Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?
Eur. Respir. J.,
May 1, 2002;
19(5):
966 - 975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. M. Wouters, E. C. Creutzberg, and A. M. W. J. Schols
Systemic Effects in COPD*
Chest,
May 1, 2002;
121
(2009):
127S - 130S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. MAESTRELLI, A. H. EL MESSLEMANI, O. DE FINA, Y. NOWICKI, M. SAETTA, C. MAPP, and L. M. FABBRI
Increased Expression of Heme Oxygenase (HO)-1 in Alveolar Spaces and HO-2 in Alveolar Walls of Smokers
Am. J. Respir. Crit. Care Med.,
October 15, 2001;
164(8):
1508 - 1513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. CAVARRA, B. BARTALESI, M. LUCATTELLI, S. FINESCHI, B. LUNGHI, F. GAMBELLI, L. A. ORTIZ, P. A. MARTORANA, and G. LUNGARELLA
Effects of Cigarette Smoke in Mice with Different Levels of alpha 1-Proteinase Inhibitor and Sensitivity to Oxidants
Am. J. Respir. Crit. Care Med.,
September 1, 2001;
164(5):
886 - 890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Devereux and A Seaton
Why don't we give chest patients dietary advice?
Thorax,
September 1, 2001;
56(90002):
ii15 - 22.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Montuschi, S. A. Kharitonov, and P. J. Barnes
Exhaled Carbon Monoxide and Nitric Oxide in COPD
Chest,
August 1, 2001;
120(2):
496 - 501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cavarra, M. Lucattelli, F. Gambelli, B. Bartalesi, S. Fineschi, A. Szarka, F. Giannerini, P. A. Martorana, and G. Lungarella
Human SLPI inactivation after cigarette smoke exposure in a new in vivo model of pulmonary oxidative stress
Am J Physiol Lung Cell Mol Physiol,
August 1, 2001;
281(2):
L412 - L417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D C Chambers and J G Ayres
Effect of nebulised L- and D-arginine on exhaled nitric oxide in steroid naive asthma
Thorax,
August 1, 2001;
56(8):
602 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zureik, F. Kauffmann, P.-J. Touboul, D. Courbon, and P. Ducimetiere
Association Between Peak Expiratory Flow and the Development of Carotid Atherosclerotic Plaques
Arch Intern Med,
July 9, 2001;
161(13):
1669 - 1676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Chapman, L. E. Otterbein, J. A. Elias, and A. M. K. Choi
Carbon monoxide attenuates aeroallergen-induced inflammation in mice
Am J Physiol Lung Cell Mol Physiol,
July 1, 2001;
281(1):
L209 - L216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A Sargeant, K.-T. Khaw, S. Bingham, N. E Day, R. N Luben, S. Oakes, A. Welch, and N. J Wareham
Cigarette smoking and glycaemia: the EPIC-Norfolk Study
Int. J. Epidemiol.,
June 1, 2001;
30(3):
547 - 554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Noguera, S Batle, C Miralles, J Iglesias, X Busquets, W MacNee, and A G N Agustí
Enhanced neutrophil response in chronic obstructive pulmonary disease
Thorax,
June 1, 2001;
56(6):
432 - 437.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B Balint, L E Donnelly, T Hanazawa, S A Kharitonov, and P J Barnes
Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke
Thorax,
June 1, 2001;
56(6):
456 - 461.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. CUZZOCREA, E. MAZZON, L. DUGO, I. SERRAINO, A. CICCOLO, T. CENTORRINO, A. DE SARRO, and A. P. CAPUTI
Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat
FASEB J,
May 1, 2001;
15(7):
1187 - 1200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. HANAZAWA, S. A. KHARITONOV, and P. J. BARNES
Increased Nitrotyrosine in Exhaled Breath Condensate of Patients with Asthma
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1273 - 1276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. PAREDI, S. A. KHARITONOV, and P. J. BARNES
Elevation of Exhaled Ethane Concentration in Asthma
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1450 - 1454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. MONTUSCHI, J. V. COLLINS, G. CIABATTONI, N. LAZZERI, M. CORRADI, S. A. KHARITONOV, and P. J. BARNES
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers
Am. J. Respir. Crit. Care Med.,
September 1, 2000;
162(3):
1175 - 1177.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. PAREDI, S. A. KHARITONOV, D. LEAK, S. WARD, D. CRAMER, and P. J. BARNES
Exhaled Ethane, a Marker of Lipid Peroxidation, Is Elevated in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
August 1, 2000;
162(2):
369 - 373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. ICHINOSE, H. SUGIURA, S. YAMAGATA, A. KOARAI, and K. SHIRATO
Increase in Reactive Nitrogen Species Production in Chronic Obstructive Pulmonary Disease Airways
Am. J. Respir. Crit. Care Med.,
August 1, 2000;
162(2):
701 - 706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M A Heunks and P N R. Dekhuijzen
Respiratory muscle function and free radicals: from cell to COPD
Thorax,
August 1, 2000;
55(8):
704 - 716.
[Full Text]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Chronic Obstructive Pulmonary Disease
N. Engl. J. Med.,
July 27, 2000;
343(4):
269 - 280.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives
Am. J. Clinical Nutrition,
May 1, 2000;
71(5):
1033 - 1047.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|